Search
for
Sort by
Research 211–240 of 1000+
- Polycystic ovary syndrome
- Polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- The Rotterdam Study: 2018 update on objectives, design and main results
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Endocrinology of Transgender Medicine
- Hormone therapy for transgender patients
- Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Safety of testosterone treatment in postmenopausal women
- Emerging medication for the treatment of male hypogonadism
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Potential adverse effects of long-term testosterone therapy
- Skin aging: are adipocytes the next target?
- Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects
- Polycystic ovary syndrome and impact on health
- Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Genetic Defects in Human Pericentrin Are Associated With Severe Insulin Resistance and Diabetes
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women